Azitra, Inc. (AZTR)
About Azitra, Inc.
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$11.0M
- Total assets
- $5.0M
- Market cap
- $3.4M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $11.0M
- Operating income
- -$11.0M
- Income tax
- $8.3K
- Net income
- -$11.0M
- EPS (basic)
- $-2.25
- EPS (diluted)
- $-2.25
Balance sheet
- Total assets
- $5.0M
- Current assets
- $3.0M
- Total liabilities
- $1.2M
- Current liabilities
- $1.1M
- Shareholders’ equity
- $3.8M
Cash flow
- Operating cash flow
- -$11.2M
- Investing cash flow
- -$182.9K
- Financing cash flow
- $8.9M
- Net cash flow
- -$2.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.4M
- EPS (diluted)
- $-2.25
- Shares outstanding
- 26.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 16, 2023
Azitra, Inc. (AZTR) Stock Price
- Reported a net loss of $11.0M in FY2025.
- Trading 93% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Azitra, Inc..
Write a review
News about Azitra, Inc.
News & sentiment via Polygon.io
Azitra, Inc.: frequently asked questions
Is Azitra, Inc. an American company?
Azitra, Inc. is a US-based company headquartered in Branford, Connecticut, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Azitra, Inc. headquartered?
Azitra, Inc. is headquartered in Branford, Connecticut, United States.
Is Azitra, Inc. publicly traded?
Yes — Azitra, Inc. is a publicly traded company. Its stock trades under the ticker symbol AZTR on the NYSE.
What does Azitra, Inc. do?
Azitra, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
